The Minor Consult

Dean Lloyd Minor welcomes Tom Hale, CEO of Oura, for a conversation about how wearable technology can help people take a more active role in their health. They discuss how an individual’s biometric data can inform everyday habits, how wearables could help clinicians identify health risks earlier, and the potential for AI to make care more proactive and personalized. Together, they explore a potential future in which continuous health monitoring could help flag risks before symptoms appear, providing more opportunities to predict and prevent disease.

Dean Lloyd Minor welcomes neurologist and author Pria Anand, MD, for a conversation about the power of narrative in neurology. They explore how symptoms such as sleep paralysis and confabulation — the brain’s tendency to fill gaps in memory — can illuminate how the brain works, and how culture shapes the way people experience, interpret, and describe illness. They also discuss what the brain’s storytelling tendencies may reveal about AI, why human connection matters for healthy aging, and how emerging imaging technologies could transform our understanding of the nervous system.

In this episode of the Big Ideas series, Dean Lloyd Minor welcomes Joseph DeSimone, PhD, professor of translational medicine and of chemical engineering at Stanford University, for a conversation about how advances in materials science and precision manufacturing are opening new frontiers in medicine. They explore DeSimone's pioneering innovations in polymer-based drug delivery, biodegradable stents, digitally fabricated dentures, high-speed 3D printing, and microneedle patches that could improve vaccine delivery and enable new forms of liquid biopsy. They also discuss the promise of AI to integrate molecular diagnostics and other health data, helping to make precision health more actionable and widely accessible.

Dean Lloyd Minor welcomes William Brody, MD, PhD, president emeritus of Johns Hopkins University, for a conversation about leadership, critical thinking, and lessons from his career spanning academia, medicine, and entrepreneurship. They discuss insights from Brody's 2026 book "Uncommon Sense: Rethinking Ordinary Problems in Extraordinary Ways," including the roles of preparation and opportunity in success, the importance of authenticity in leadership and the value of building meaningful relationships over collecting accolades. They also explore Brody’s philosophy as president of Johns Hopkins, as well as the benefits of questioning conventional wisdom.

In this episode of the Big Idea series, Dean Lloyd Minor welcomes Freddy Abnousi, MD, vice president of health technology at Meta and an interventional cardiologist, for a conversation about how artificial intelligence and augmented reality have the potential to transform preventative health care. They discuss how ambient AI, wearables, and smart glasses can capture valuable health information from “lived experience” that is often missed in medical records, helping to avert or manage chronic conditions. They also explore the critical challenges ahead for AI in health, from privacy concerns to workflow integration, as well as what these rapid advances mean for the future of medical education.

Dean Lloyd Minor welcomes Eric Horvitz, MD, PhD, chief scientific officer at Microsoft, for a conversation about the rapid evolution of AI and its implications for how we think, work, and make decisions. They discuss the accelerating pace of AI advances, the need to safeguard human judgment and agency, and the growing role of these technologies in health care — from easing administrative burden to supporting complex clinical decisions. They also explore how AI is reshaping scientific discovery and what it will take to guide its development responsibly.

Dean Lloyd Minor welcomes Dhruv Khullar, MD, contributing writer to The New Yorker and associate professor at the Weill Cornell School of Medicine, for a conversation about AI’s evolving role in health care. They discuss its potential to enhance diagnosis, reduce administrative burden, improve the patient experience, and accelerate drug discovery, while also examining the risks of overreliance and clinician de-skilling. They also explore how AI will reshape medical education, and why communication, trust, and the enduring practice of healing will remain central to the future of medicine.

In this episode of the Big Idea series, Dean Lloyd Minor welcomes Lucy Shapiro, PhD, for a conversation about how her unconventional thinking unlocked new insights about how bacterial cells behave, fundamentally changing how scientists understand cells and laying the groundwork for systems biology. They explore how her research informed new approaches to treating infections and other diseases, and how these advances opened new paths for developing antibacterial and antifungal drugs to fight superbugs. They also discuss the biological threat posed by antimicrobial resistance and ways that the global community can prepare for the next pandemic.

Dean Lloyd Minor welcomes Sarah Soule, Dean of the Stanford Graduate School of Business, for a conversation about how leaders, organizations, and the GSB itself are evolving in a rapidly changing world. During the GSB’s centennial year, they explore the school’s leadership model — emphasizing self-awareness, perspective taking, communication, and deep listening — and how its entrepreneurial culture has inspired alumni whose bold ideas became transformative companies. They also discuss the future or organizational behavior and her vision for the school’s next chapter, including new initiatives in investing, leadership development, and the future of work and AI.

In this episode of the Big Idea series, Dean Lloyd Minor welcomes Eric Topol, MD, author of Super Agers: An Evidence-Based Approach to Longevity, for a conversation about why immune health may be more important than genetics in promoting healthy aging. They explore how lifestyle factors like sleep, diet, and exercise strengthen the body’s defenses, shaping longevity beyond our genes. They also discuss how emerging technologies, from wearable sensors to genetic risk tools, could make personalized prevention a reality for all.

In an episode of his Big Idea series, Dean Lloyd Minor welcomes Stanford neuroscientist Karl Deisseroth, MD, PhD, for a conversation about how his groundbreaking research is reshaping our understanding of the brain and the experiences that define us as human. They delve into the origins of optogenetics — a revolutionary technology Deisseroth pioneered using light to map how the brain drives emotion and behavior — and they explore his vision for Stanford Medicine’s Human Neural Circuitry research program. Deisseroth also reflects on the beauty of scientific discovery, the role of humility in research, and how advances in brain science are opening new avenues for understanding and treating mental illness.

Dean Lloyd Minor welcomes Jeremy Kahn, award-winning journalist and AI Editor at Fortune, for a conversation about the transformative potential and societal risks of artificial intelligence. They discuss opportunities for AI to accelerate medical breakthroughs and personalize education, as well as the threat of overreliance on AI to critical thinking, writing, and social skills. They also explore how AI is reshaping jobs and business models, the role of regulation in balancing innovation with safety, and the geopolitical stakes as global competition in AI intensifies.

Dean Lloyd Minor welcomes Regina Dugan, CEO of Wellcome Leap, for a conversation about how to tackle complex global challenges through bold innovation. They discuss why emotional engagement is essential to achieving scientific progress, how high-risk, high-reward models can translate to health research, and the importance of addressing underfunded areas, such as women’s health. They also explore strategies for removing barriers to innovation and how redefining failure can lead to more meaningful progress.

Dean Lloyd Minor welcomes JPMorganChase Vice Chairman Peter Scher for a conversation about the evolving role of corporate responsibility and its intersection with business strategy. They discuss Scher’s leadership in JPMorganChase’s $200 million investment to revitalize the city of Detroit, as well as the firm’s work in other urban environments supporting business and growing communities. They also explore his work with Morgan Health, the firm’s business unit focused on improving the quality and delivery of employer-based health care, and how AI, data, and innovation are reshaping health care.

Dean Lloyd Minor welcomes Thrive Global CEO Arianna Huffington for a conversation about the connection between mental health and physical health and how tiny changes to behavior can have a profound impact. They discuss the transformative moment that led to Arianna’s pivot to wellness in 2016, and they explore the potential for AI to democratize personalized health coaching and make a meaningful difference across communities.

In a special episode recorded in front of a live audience, Dean Lloyd Minor welcomes Stanford’s legendary women’s basketball coach Tara VanDerveer for a discussion about her extraordinary 40-year career. They discuss the coaching philosophy that led her teams to three NCAA Championship titles and an Olympic gold medal, along with her approach to developing talent and fostering resilience. They also explore the art of making half-time adjustments, learning as a leader, and the future of women’s athletics.

Dean Lloyd Minor welcomes Daphne Koller, PhD, founder and CEO of insitro, for a conversation about AI’s potential to transform drug discovery. They discuss how machine learning algorithms can accelerate the drug design process, quickly identifying biological patterns and predicting outcomes. They also explore the challenges and opportunities of founding a startup in Silicon Valley, and how insitro’s collaborations with large pharmaceutical companies are advancing therapeutics for Amyotrophic lateral sclerosis (ALS) and other conditions.

Dean Lloyd Minor welcomes Dr. Karen DeSalvo, Google’s Chief Health Officer, for a conversation about how AI can help inform and advocate for patients while supporting clinicians and increasing access to care around the world. They discuss AI tools that Google has developed to accelerate diagnostics, particularly in lower-resource areas, and they explore the potential for AI to serve as a personal health assistant for patients. They also discuss Google’s strategy for providing accurate, meaningful health information to the general public, and the challenges and opportunities of integrating AI technologies into clinical care.

Dean Lloyd Minor welcomes Meena Seshamani, MD, PhD, director of the federal Center for Medicare at the Centers for Medicare & Medicaid Services, for a conversation about supporting holistic health care through the country’s government insurance program for seniors. They discuss Medicare’s role in advancing prescription drug affordability and the importance of family caregivers and community workers in helping seniors attain their optimal health. They also explore practical approaches Medicare has deployed to advance health equity, and discuss what needs to be done to ensure the program’s financial strength and viability for generations to come.

Dean Lloyd Minor welcomes Michael Pfeffer, MD, chief information and digital officer at Stanford Health Care, and Nigam Shah, MBBS, PhD, the health system’s chief data scientist, for a conversation about how AI is being used to augment health care. They explore how AI is helping clinicians access troves of data to inform patient care and how it’s helping ease their clerical burden, allowing more time for meaningful interactions with patients. They also discuss the guardrails in place to protect privacy and ensure reliability, as well as what is needed to scale AI tools to benefit as many patients as possible.